Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. 2008

Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
Department of Pediatric Endocrinology, Regina Margherita Children's Hospital, Turin, Italy. silvein@libero.it

BACKGROUND A 4-week course of high-dose glucocorticoids may cause prolonged adrenal suppression even after a 9-day tapering phase. In this study, adrenal function and signs and symptoms of adrenal insufficiency were prospectively assessed in children with acute lymphoblastic leukemia (ALL) after induction treatment including high-dose prednisone (PDN) or dexamethasone (DXM). METHODS Sixty-four children with ALL, treated according to the AIEOP ALL 2000 Study protocol, underwent low dose ACTH (LD-ACTH) stimulation 24 hr after the last tapered steroid dose. In those with impaired cortisol response, additional LD ACTH tests were performed every 1-2 weeks until cortisol levels normalized. Signs and symptoms of adrenal insufficiency were recorded during the observation period. RESULTS All patients had normal basal cortisol values at diagnosis. Twenty-four hours after last glucocorticoid dose, morning cortisol was reduced in 40/64 (62.5%) patients. LD-ACTH testing showed adrenal suppression in 52/64 (81.5%) patients. At the following ACTH test 7-14 days later, morning cortisol values were reduced in 8/52 (15.4%) patients and response to the test was impaired in 12/52 (23%). Adrenal function completely recovered in all patients within 10 weeks. No difference was found between patients treated with PDN or DXM. Almost 35% of children with impaired cortisol values at the first test developed signs or symptoms of adrenal insufficiency. One child developed a severe adrenal crisis during adrenal suppression. CONCLUSIONS High-dose glucocorticoid therapy in ALL children may cause prolonged adrenal suppression and related clinical symptoms. Laboratory monitoring of cortisol levels and steroid coverage during stress episodes may be indicated.

UI MeSH Term Description Entries
D008297 Male Males
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
September 2020, European journal of pediatrics,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
September 2012, Psychoneuroendocrinology,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
January 1998, Cancer,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
January 1993, Current opinion in oncology,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
August 2003, Medical and pediatric oncology,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
March 2012, Journal of cancer survivorship : research and practice,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
November 2017, The Cochrane database of systematic reviews,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
May 2012, The Cochrane database of systematic reviews,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
August 2015, The Cochrane database of systematic reviews,
Silvia Einaudi, and Nicoletta Bertorello, and Nicoletta Masera, and Loredana Farinasso, and Elena Barisone, and Carmelo Rizzari, and Andrea Corrias, and Alessia Villa, and Francesca Riva, and Paola Saracco, and Guido Pastore
August 2017, Expert opinion on pharmacotherapy,
Copied contents to your clipboard!